Supplemental Reference
1. Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, Xu AH, Huang X, Zhou MJ, Fang Q,
Zhang DZ. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013;34:2843–8.
2. Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, Kavcova E, Jakusova V,
Janickova M, Drgova A, Berzinec P, Halasova E. DNA repair genes polymorphism and lung cancer risk with
the emphasis to sex differences. Mol Biol Rep. 2013;40:5261–73.
3. Mohamed FZ, Hussien YM, AlBakry MM, Mohamed RH, Said NM. Role of DNA repair and cell cycle
control genes in ovarian cancer susceptibility. Mol Biol Rep. 2013;40:3757–68.
4. Li RZ, Sun J. Association between XPD gene polymorphisms and esophageal squamous cell carcinoma. Mol
Med Rep. 2013;7:674–8.
5. Guo LY, Jin XP, Niu W, Li XF, Liu BH, Wang YL. Association of XPD and XRCC1 genetic polymorphisms
with hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13:4423–26.
6. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, Autrup H, Malaveille C, Peluso M,
Airoldi L, Veglia F, Gormally E, Hoek G, Krzyzanowski M, Overvad K, Raaschou-Nielsen O,
Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S,
Bueno-De-Mesquita HB, Peeters PH, Lund E, Pera G, Martinez C, Dorronsoro M, Barricarte A, Tormo MJ,
Quiros JR, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Vineis P. DNA repair polymorphisms and cancer
risk in non-smokers in a cohort study. Carcinogenesis. 2006;27:997–1007.
7. Gulnaz A, Sayyed AH, Amin F, Khan AU, Aslam MA, Shaikh RS, Ali M. Association of XRCC1, XRCC3,
and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B
and C virus. Eur J Gastroenterol Hepatol. 2013;25:166–79.
8. Khokhrin DV, Khrunin AV, Moiseev AA, Gorbunov VA, Limborskaia SA. Association of polymorphisms in
glutathione-S-transferase and DNA repair genes with ovarian cancer risk in the Russian population. Genetika.
2012;48:901–4.
9. Zhou M, Wan HY, Gao BL, Ding YJ, Jun RX. Genetic polymorphisms of XPD and CDA and lung cancer
risk. Oncol Lett. 2012;4:247–51.
10. Ji YB, Tae K, Lee YS, Lee SH, Kim KR, Park CW, Park BL, Shin HD. XPD Polymorphisms and Risk of
Squamous Cell Carcinoma of the Head and Neck in a Korean Sample. Clin Exp Otorhinolaryngol. 2010;3:
42–7.
11. Abramenko I, Bilous N, Chumak A, Kostin A, Martina Z, Dyagil I. DNA repair polymorphisms in B-cell
chronic lymphocytic leukemia in sufferers of Chernobyl Nuclear Power Plant accident. J Radiat Res. 2012;
53:497–503.
12. Sobczuk A, Poplawski T, Blasiak J. Polymorphisms of DNA repair genes in endometrial cancer. Pathol Oncol
Res. 2012;18:1015–20.
13. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen
metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7:954–62.
14. Hernández-Boluda JC, Pereira A, Cervantes F, Alvarez-Larrán A, Collado M, Such E, Arilla MJ, Boqué C,
Xicoy B, Maffioli M, Bellosillo B, Marugán I, Amat P, Besses C, Guillem V. A polymorphism in the XPD
gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia
and polycythemia vera. Blood. 2012;119:5221–8.
15. Kostrzewska-Poczekaj M, Gawęcki W, Illmer J, Rydzanicz M, Gajecka M, Szyfter W, Szyfter K.
Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young
adults. Eur Arch Otorhinolaryngol. 2013;270:271–6.
16. Slyskova J, Naccarati A, Pardini B, Polakova V, Vodickova L, Smerhovsky Z, Levy M, Lipska L, Liska V,
Vodicka P. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer
patients and healthy controls. Mutagenesis. 2012;27:225–32.
17. Cifci S, Yilmaz M, Pehlivan M, Sever T, Okan V, Pehlivan S. DNA repair genes polymorphisms in multiple
myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and
G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients.
Hematology. 2011;16:361–7.
18. Sobti RC, Berhane N, Melese S, Mahdi SA, Gupta L, Thakur H, Singh N. Impact of XPD gene polymorphism
on risk of prostate cancer on north Indian population. Mol Cell Biochem. 2012;362:263–8.
19. Wang YH, Yeh SD, Shen KH, Shen CH, Tung MC, Liu CT, Chiou HY. Association of hOGG1 and XPD
polymorphisms with urothelial carcinoma in Taiwan. Anticancer Res. 2011;31:3939–44.
20. Kumar A, Pant MC, Singh HS, Khandelwal S. Associated risk of XRCC1 and XPD cross talk and life style
factors in progression of head and neck cancer in north Indian population. Mutat Res. 2012;729:24–34.
21. Doherty JA, Weiss NS, Fish S, Fan W, Loomis MM, Sakoda LC, Rossing MA, Zhao LP, Chen C.
Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiol
Biomarkers Prev. 2011;20:1873–82.
22. Sobti RC, Kaur S, Sharma VL, Singh SK, Hosseini SA, Kler R. Susceptibility of XPD and RAD51 genetic
variants to carcinoma of urinary bladder in North Indian population. DNA Cell Biol. 2012; 31:199–210.
23. Kong FJ, Xu WS, Wang HL, et al. Association of the mono-nucleotide polymorphism had DNA repair
gene XPD with the risk of lung cancer. Prac J Med Pharm. 2008;10:1161–3.
24. Rouissi K, Ouerhani S, Hamrita B, Bougatef K, Marrakchi R, Cherif M, Ben Slama MR, Bouzouita M,
Chebil M, Ben Ammar Elgaaied A. Smoking and polymorphisms in xenobiotic metabolism and DNA repair
genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathol Oncol Res. 2011;
17:879–86.
25. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, Autrup H, Malaveille C, Peluso M,
Airoldi L, Veglia F, Gormally E, Hoek G, Krzyzanowski M, Overvad K, Raaschou-Nielsen O,
Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S,
Bueno-De-Mesquita HB, Peeters PH, Lund E, Pera G, Martinez C, Dorronsoro M, Barricarte A, Tormo MJ,
Quiros JR, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Vineis P. DNA repair polymorphisms and cancer
risk in non-smokers in a cohort study. Carcinogenesis. 2006;27:997–1007.
26. Canbay E, Cakmakoglu B, Zeybek U, Sozen S, Cacina C, Gulluoglu M, Balik E, Bulut T, Yamaner S, Bugra
D. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr
Med Res Opin. 2011;27:1295–302.
27. Gil J, Ramsey D, Stembalska A, Karpinski P, Pesz KA, Laczmanska I, Leszczynski P, Grzebieniak Z,
Sasiadek MM. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of
an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep. 2012;39:527–34.
28. Huang CG, Liu T, Lv GD, Liu Q, Feng JG, Lu XM. Analysis of XPD genetic polymorphisms of esophageal
squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Mol Biol Rep. 2012;
39:709–714.
29. Canalle R, Silveira VS, Scrideli CA, Queiroz RG, Lopes LF, Tone LG. Impact of thymidylate synthase
promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia.
Leuk Lymphoma. 2011;52:1118–26.
30. Rouissi K, Bahria IB, Bougatef K, Marrakchi R, Stambouli N, Hamdi K, Cherif M, Ben Slama MR, Sfaxi M,
Othman FB, Chebil M, Elgaaied AB, Ouerhani S. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic
variants in bladder cancer development. BMC Cancer. 2011;11:101.
31. Gugatschka M, Dehchamani D, Wascher TC, Friedrich G, Renner W. DNA repair gene ERCC2
polymorphisms and risk of squamous cell carcinoma of the head and neck. Exp Mol Pathol. 2011;91:331–4.
32. Engin AB, Karahalil B, Engin A, Karakaya AE. DNA repair enzyme polymorphisms and oxidative stress in a
Turkish population with gastric carcinoma. Mol Biol Rep. 2011;38:5379–86.
33. Osawa K, Miyaishi A, Uchino K, Osawa Y, Inoue N, Nakarai C, Tsutou A, Kido Y, Yoshimura M, Tsubota
N, Takahashi J. APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking
in Japanese. Asian Pac J Cancer Prev. 2010;11:1181–6.
34. Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair
pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.
35. Samson M, Singh SS, Rama R, Sridevi V, Rajkumar T. XPD Lys751Gln increases the risk of breast cancer.
Oncol Lett. 2011;2:155–9.
36. Huang CG, Iv GD, Liu T, Liu Q, Feng JG, Lu XM. Polymorphisms of COMT and XPD and risk of
esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Biomarkers.
2011;16:37–41.
37. Chen Z, Zhang C, Xu C, Li K, Hou R, Li D, Cheng X. Effects of selected genetic polymorphisms in
xeroderma pigmentosum complementary group D on gastric cancer. Mol Biol Rep. 2011;38:1507–13.
38. Palli D, Polidoro S, D'Errico M, Saieva C, Guarrera S, Calcagnile AS, Sera F, Allione A, Gemma S, Zanna I,
Filomena A, Testai E, Caini S, Moretti R, Gomez-Miguel MJ, Nesi G, Luzzi I, Ottini L, Masala G, Matullo
G, Dogliotti E. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer.
Mutagenesis. 2010;25:569–75.
39. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, Widlak P.
Association between single-nucleotide polymorphisms of selected genes involved in the response to
DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010;
51:343–52.
40. Engin AB, Karahalil B, Engin A, Karakaya AE. Oxidative stress, Helicobacter pylori, and OGG1 Ser326Cys,
XPC Lys939Gln, and XPD Lys751Gln polymorphisms in a Turkish population with colorectal carcinoma.
Genet Test Mol Biomarkers. 2010;14:559–64.
41. Sliwinski T, Przybylowska K, Markiewicz L, Rusin P, Pietruszewska W, Zelinska-Blizniewska H, Olszewski
J, Morawiec-Sztandera A, Mlynarski W, Majsterek I. MUTYH Tyr165Cys, OGG1 Ser326Cys and
XPD Lys751Gln polymorphisms and head neck cancer susceptibility: a case–control study. Mol Biol Rep.
2011;38:1251–61.
42. Srivastava K, Srivastava A, Mittal B. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and
gallbladder cancer risk in a population of Northern India. Cancer. 2010;116:3160–9.
43. Canbay E, Agachan B, Gulluoglu M, Isbir T, Balik E, Yamaner S, Bulut T, Cacina C, Eraltan IY, Yilmaz A,
Bugra D. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with
prognosis in gastric cancer. Anticancer Res. 2010;30:1359–64.
44. Gao W, Romkes M, Zhong S, Nukui T, Persad RA, Smith PJ, Branch R, Keohavong P. Genetic
polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
Oncol Rep. 2010;24:257–62.
45. Gao R, Price DK, Dahut WL, Reed E, Figg WD. Genetic polymorphisms in XRCC1 associated with radiation
therapy in prostate cancer. Cancer Biol Ther. 2010;10:13–8.
46. Wang HC, Liu CS, Wang CH, Tsai RY, Tsai CW, Wang RF, Chang CH, Chen YS, Chiu CF, Bau DT, Huang
CY. Significant association of XPD Asp312Asn polymorphism with breast cancer in Taiwanese patients. Chin J Physiol. 2010;53:130–5.
47. Shi JY, Ren ZH, Jiao B, Xiao R, Yun HY, Chen B, Zhao WL, Zhu Q, Chen Z, Chen SJ. Genetic variations of
DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. Int J Cancer.
2011;128:233–8.
48. Long XD, Ma Y, Huang YZ, Yi Y, Liang QX, Ma AM, Zeng LP, Fu GH. Genetic polymorphisms in DNA
repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection-related gastric
antrum adenocarcinoma in Guangxi population, China. Mol Carcinog. 2010;49:611–8.
49. Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q. Modulation
of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res
2011;61:1354–7.
50. Ming-Shiean H, Yu JC, Wang HW, Chen ST, Hsiung CN, Ding SL, Wu PE, Shen CY, Cheng CW.
Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female
breast cancer risk. Ann Surg Oncol. 2010;17:760–71.
51. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman
N, Linet MS, Inskip PD. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and
acoustic neuroma. Neuro Oncol. 2010;12:37–48.
52. Mandal RK, Gangwar R, Mandhani A, Mittal RD. DNA repair gene X-ray repair cross-complementing group
1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
DNA Cell Biol. 2010;29:183–90.
53. Yin Z, Su M, Li X, Li M, Ma R, He Q, Zhou B. ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil
fume and lung adenocarcinoma risk in Chinese non-smoking females. J Exp Clin Cancer Res. 2009;28:153.
54. Zeng XY, Qiu XQ, Ji L, Yu HP. Study on the relationship between hepatocellular carcinoma and the
interaction between polymorphisms in DNA repair gene XPD and environmental factors. Zhonghua Liu Xing
Bing Xue Za Zhi. 2009;30:702–5.
55. Yang F, Shi JY, Xu L, Ren LJ, Zhang QH, Zhao WL, Shen ZX. Genetic susceptibility of single nucleotide
polymorphism in MGMT to non-Hodgkin lymphoma. Zhonghua Xue Ye Xue Za Zhi. 2009; 30:622–5.
56. Long XD, Ma Y, Zhou YF, Yao JG, Ban FZ, Huang YZ, Huang BC. XPD codon 312 and 751
polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer. 2009;9:400.
57. Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA
repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control. 2010;
21:289–300.
58. Zhang CZ, Chen ZP, Xu CQ, Ning T, Li DP, Hou RP. Correlation of XPD gene with susceptibility to gastric
cancer. Ai Zheng. 2009;28:1163–7.
59. Chang CH, Wang RF, Tsai RY, Wu HC, Wang CH, Tsai CW, Chang CL, Tsou YA, Liu CS, Bau DT.
Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility
in Taiwan. Anticancer Res 2009;29:3903–7.
60. Zhai XD, Mo YN, Xue XQ, Zhao GS, Gao LB, Ai HW, Ye Y. XRCC1 codon 280 and ERCC2 codon 751
polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population. Bull Cancer. 2009;
96:E61–5.
61. Lavender NA, Komolafe OO, Benford M, Brock G, Moore JH, Vancleave TT, States JC, Kittles RA, Kidd
LC. No association between variant DNA repair genes and prostate cancer risk among men of African
descent. Prostate. 2010;70:113–9.
62. Worrillow L, Roman E, Adamson PJ, Kane E, Allan JM, Lightfoot TJ. Polymorphisms in the nucleotide